For US residents only.

Frequently Asked Questions

GLEEVEC

Questions and Answers About GLEEVEC

Click below for answers to some of the most frequently asked questions about GLEEVEC® (imatinib mesylate) tablets.

Expand all

If you and your doctor decide that branded GLEEVEC is right for you, you can take these steps to ensure you receive it at every refill:

 

  • Your doctor can write “Dispense as Written” (“DAW”), or your state or territory’s required language, on your prescription.

 

  • While at the pharmacy, or while placing a mail order, you can verify with the pharmacist that your doctor’s preference is for branded GLEEVEC. You also have the option to notify the pharmacist that your preference is for branded medication even if your doctor did not write "Dispense as Written," or your state or territory's required language, on your prescription.

 

  • Once you receive your medication at the pharmacy, verify that your pills are branded GLEEVEC. If they are not, you can call your doctor to discuss your options.

 

Your health insurance plan is an important factor in determining the out-of-pocket expenses for branded and generic medication. In addition, statutes related to a state or territory’s specific DAW requirements can affect your costs. Note that there may be a difference in cost between branded GLEEVEC and generics.

Novartis is committed to making sure branded GLEEVEC is available, but we can’t control what medications individual pharmacies stock. If your pharmacy doesn’t stock branded GLEEVEC, you can ask the pharmacy to special order it for you, which usually can be delivered in a day.

If this occurs, call 1-800-282-7630 to speak with a member of our knowledgeable staff dedicated to making access to therapy as simple and convenient as possible; or visit: www.PatientSupportMadeSimple.com

Yes. The following are some organizations that may be able to provide you with additional information, assistance, or emotional support.

 

 

The organizations listed here are maintained by third parties over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation makes no representation as to the accuracy or any other aspect of the information supplied by these organizations or contained in these websites.

In February 2016, the first FDA-approved generic form of GLEEVEC became available in the United States. Since that time, other manufacturers have been granted approval to produce generic forms of GLEEVEC. Please speak with your doctor or pharmacist for more information.

Your medication costs can vary based on a variety of factors, such as insurance coverage and/or government assistance programs, and the costs set by the manufacturer.

The pharmacy may substitute a generic form in place of branded GLEEVEC. Talk to your doctor for more information.

A generic may appear different from branded GLEEVEC in characteristics such as pill shape, size, and color. In addition, now that there are multiple generic versions of GLEEVEC, pill appearance may vary from refill to refill, depending on which generic the pharmacy has in stock. However, even though the generic pill may appear different, the FDA requires that generic medications contain the same active ingredient as the brand name, and that they function comparably in your body.

Your out-of-pocket costs may change based on your insurance plan design, or from other factors, which can change throughout the year. For help call 1-800-282-7630 to speak with a member of our knowledgeable staff dedicated to making access to therapy as simple and convenient as possible; or visit: www.PatientSupportMadeSimple.com. Other financial assistance may also be available.

Please contact the generic drug manufacturers or speak to your doctor or pharmacist with questions related to generic imatinib mesylate.